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Stem cell-derived hepatocyte-like cells hold great potential for the treatment of liver disease and for drug toxicity
screening. The success of these applications hinges on the generation of differentiated cells with high liver
specific activities. Many protocols have been developed to guide human embryonic stem cells (hESCs) to
differentiate to the hepatic lineage. Here we report cultivation of hESCs as three-dimensional aggregates that
enhances their differentiation to hepatocyte-like cells. Differentiation was first carried out in monolayer culture
for 20 days. Subsequently cells were allowed to self-aggregate into spheroids. Significantly higher expression of
liver-specific transcripts and proteins, including Albumin, phosphoenolpyruvate carboxykinase, and asia-
loglycoprotein receptor 1 was observed. The differentiated phenotype was sustained for more than 2 weeks in
the three-dimensional spheroid culture system, significantly longer than in monolayer culture. Cells in spheroids
exhibit morphological and ultrastructural characteristics of primary hepatocytes by scanning and transmission
electron microscopy in addition to mature functions, such as biliary excretion of metabolic products and cyto-
chrome P450 activities. This three-dimensional spheroid culture system may be appropriate for generating high
quality, functional hepatocyte-like cells from ESCs.
Introduction
Treatments for end stage liver failure are largely de-pendent on liver organ or hepatocyte cell transplantation,
which are limited by the availability of donor organs or cells
[1–3]. Severe end-stage liver disease may benefit from an ex-
tracorporeal bioartificial liver (BAL) device as a bridge to liver
transplantation or even regeneration [4,5]. However, such
BAL devices for extracorporeal liver support have to resort to
xenogeneic cell sources or tumorigenic cell lines because of the
lack of human hepatocytes. A renewable cell source, espe-
cially stem cell-derived human hepatocytes, will greatly en-
hance the prospect of liver cell based therapy [6]. Stem cell-
derived hepatocytes may also find applications in drug me-
tabolism and toxicity studies [7–9]. Successful derivation of
hepatocytes from pluripotent human stem cells will therefore,
ensure virtually unlimited cell sources for discovery and
clinical applications.
Human embryonic stem cells (hESCs) cultured under low
adhesive conditions form aggregates called embryoid bodies
(EBs). They have a propensity to spontaneously differentiate
to multiple cell lineages, including the hepatic endoderm, but
at a rather low efficiency [10]. In contrast directed and con-
trolled differentiation to hepatic lineage has had more success
in many laboratories [11–14]. These directed differentiation
protocols entail plating of hESC on extracellular matrices and
treatment with a series of cocktails of cytokines and growth
factors to promote hepatic differentiation as evidenced by the
presence of liver markers [15].
We recently described a 20-day, four stage protocol for
differentiation of ES and induced pluripotent stem cells (iPS),
from both human and mouse, to cells of hepatic lineage [11].
Cells grown to confluency on matrigel were guided toward
definitive endoderm with Activin-A and Wnt3a, followed by
specification to hepatic endoderm by treatment with bone
morphogenetic protein (BMP)4 and basic fibroblast growth
factor (bFGF), to bipotential hepatoblasts using aFGF,
FGF4b, and FGF8, and finally toward a hepatocyte-like cell
state by treatment with hepatocyte growth factor (HGF) and
Follistatin. This stepwise treatment results in *10%–20% of
the cell population demonstrating a fetal hepatocyte-like
with some characteristics of adult hepatocytes.
Others have used similar sets of growth factors invariably
encompassing combinations of Activin A, Wnt3, bFGF, BMP-
4, HGF, Oncostatin M, and/or Dexamethasone (Dex) [16,17].
The number of stages, in which different combinations of
growth factors are used, differ somewhat, in various proto-
cols, ranging from three to five.
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The current directed differentiation protocols give rise to
heterogeneous populations. The transcript levels of many
key hepatic genes are still relatively low. The yields of he-
patocyte-like cells, as well as their functional maturity, need
to be further enhanced. Furthermore, the differentiated he-
patic functions in those cells need to be sustained for a longer
period for most applications.
Primary hepatocytes, when cultured on a surface with a
decreased adhesiveness and at a subconfluent density, self-
assemble into spheroids that exhibit enhanced levels of a
variety of hepatic functions. They sustain hepatic functions
over a longer period in culture than the monolayer culture
[18,19].
We previously applied our differentiation protocol to di-
rect the differentiation of rat multipotent adult progenitor
cells cultivated as 3D aggregates to hepatic lineage. The re-
sulting hepatocyte-like cells had higher liver specific func-
tions, including albumin (ALB) and urea secretion and
cytochrome P450 (CYP450) activity, than those obtained
from monolayer culture [20]. Here we examined the effect of
cultivation of hESCs in 3D spheroids on the maturation of
the hepatocyte-like progeny. As hESCs differentiate sponta-
neously when cultivated as EBs, they were thus, first dif-
ferentiated toward hepatic lineage in monolayer cultures for
20 days, and then formed spheroids. We report here the
enhanced maturation and liver functions for hESC-derived
hepatocyte like cells cultured as spheroids.
Materials and Methods
HESC culture
The hESC line HSF6 was cultured as previously described
(1). Briefly, hESCs were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) (Gibco/BRL), 20% Knockout Ser-
um Replacement (Gibco), 2mM glutamine, 0.1mM nones-
sential amino acids, 0.1mM b-mercaptoethanol, and bFGF
(R&D) (4 ng/mL) on mouse embryonic fibroblasts (MEFs).
MEFs were derived from E13–E14 CF-1 mice (Charles River
Laboratories) and mitotically inactivated using gamma ra-
diation (3,000 rads). hESCs were plated on the MEFs and
cultured in hESC medium at 37C in 10% CO2. The cells were
routinely passaged using 0.1% (w/v) Collagenase Type IV
(Gibco) in ES basal media every 3–5 days.
Hepatocyte differentiation
HSF6 cells were plated in 12 well plates, precoated with
2% matrigel (BD Biosciences) in MEF-conditioned media
(CM) until 50% confluency was reached. To initiate differ-
entiation, the CM was aspirated, the cells were washed once
with PBS, and differentiation medium was added. The dif-
ferentiation basal medium consisted of a 60/40 (v/v) mix-
ture of low glucose DMEM (Gibco) and MCDB-201 (Sigma),
and supplemented with 0.026mg/mL ascorbic acid 3-phos-
phate (Sigma), linoleic acid bovine serum albumin (LA-BSA;
Sigma) (1mg/mL BSA and 8.13 mg/mL LA), insulin-trans-
ferrin-selenium (Sigma) (2.5 mg/mL insulin, 1.38 mg/mL
transferrin, 1.25 ng/mL sodium selenite), 0.4 mg/mL Dex
(Sigma), 4.3 mg/mL b-mercaptoethanol (Hyclone), 100 IU/
mL penicillin and 100mg/mL streptomycin (Gibco) and
qualified fetal bovine serum [2% (v/v) for the first 6 days
and 0.5% (v/v) for the subsequent time period).
Cytokines and growth factor were supplemented as fol-
lows: (1) D0: Activin A (100 ng/mL) and Wnt3a (50 ng/mL)
(2) D6: bFGF (10 ng/mL) and BMP4 (50 ng/mL) (3) D10:
FGF8b (25 ng/mL), aFGF (50 ng/mL) and FGF4 (10 ng/mL)
(4) D14: HGF (20 ng/mL) and Follistatin (100 ng/mL). 50%
media change was performed every 2 days using medium of
the corresponding differentiation stage. On D0, D6, D10, and
D14, medium was completely replaced with fresh medium of
the ensuing differentiation stage after a brief rinse with PBS.
Formation of hepatic spheroids
Cells were detached after treatment with 0.1% (w/v) col-
lagenase (type IV) (Invitrogen) for 15–20min at 37C. After
centrifugation (1,000 rpm 5min) the cell pellet was treated
with 0.05% (w/v) trypsin with 2% (v/v) chicken serum
(37C, 10min). The cell suspension was then passed through
a 100mm nylon mesh to obtain a single cell suspension.
Approximately 8,000 cells in 100 mL of stage IV differenti-
ation medium was added to each well of an ultra-low at-
tachment (ULA) round bottomed 96 well plate (Corning).
After centrifugation for 4min at 1,500 rpm (400g), cells set-
tled to the bottom of the well to form spheroids in the fol-
lowing 2 to 3 days.
Characterization of spheroids
Quantitative real time PCR was used to measure the tran-
script levels of hepatic genes. Flow cytometry was used to
quantify the cell fraction exhibiting mature hepatic markers
using antibodies for asialoglycoprotein receptor (ASGPR;
Thermoscientific, 1:10 dilution) and phosphoenolpyruvate
carboxykinase (PEPCK; Santa-Cruz, H-300, 1:2,000 dilution).
The secondary antibodies used were anti-mouse IgG1 A488
labeled (Molecular Probes, 1:500 dilution) and anti-rabbit IgG
A488 (Molecular Probes, 1:500 dilution). The secretion of ALB
was measured by Enzyme-linked immunosorbent assay and
CYP450 activities were imaged and quantified by biotrans-
formation of fluorogenic substrate [21]. Biliary secretion was
monitored through fluorescein activity. Ultrastructural fea-
tures were assessed using scanning and transmission electron
microscopy (TEM). Details of these assays can be found in
Supplementary Material and Methods section; Supplementary
Data are available online at www.liebertpub.com/scd
Results
Three-dimensional spheroid formation
The hESC line, HSF6, was differentiated towards the he-
patic lineage as described [11]. On D20, cells were detached
for formation of three-dimensional spheroids. Typically, we
obtained 4· 105 cells/cm2 from the monolayer culture with
high viability (> 90%). Approximately 8,000 cells were added
to each well of a U-bottom ULA culture plates. Over time
*40% of the cells in each well form multiple small clusters,
which progressively agglomerate into larger clusters in 2
days. The viability immediately after seeding was very high
(Fig. 1). At 24 h, cells within the clusters remained viable,
while individual cells not in clusters were no longer viable.
Subsequently cells in the cluster became more compact and
the size of the aggregate decreases somewhat (Fig. 1a). Six
days after the initiation of 3D formation (D26) the surface of
ENHANCING HEPATIC DIFFERENTIATION OF ES CELLS 125
all the spheroids becomes relatively smooth. There is no
evidence of cell proliferation. The diameter of the compacted
spheroids ranges from 94 to 293 mm, with an average of
about 150mm (Supplementary Fig. S1). Additional images of
spheroid formation on days D0 to D7 are shown in Supple-
mentary Fig. S2.
Time-lapse microscopy was employed to directly observe
the early stages of spheroid formation (Fig. 1f–i; Supplemen-
tary Video S1). A small fraction (1%) of the cells was labeled
with Vybrant DiI membrane dye before they were placed into
ULA well to facilitate the tracking of individual cells amongst
the bulk population. Cells were seen to be incorporated into
the aggregating cell clusters in proximity to their initial posi-
tion. However, a small fraction of cells did move over dis-
tances, before being incorporated into an aggregate. These
data suggest that cell incorporation into spheroids is not a
random process, but selectively enriches viable cells.
Expression of hepatic genes in 3D spheroids
The expression of several hepatic-specific genes in spher-
oid culture was evaluated and compared to cells maintained
in monolayer culture until D26. Results are presented as ratio
of transcripts of D26 cells to D20 cells in monolayer culture
(Fig. 2). The transcript levels for all liver specific genes tested
increased in D26 spheroids from D20 and are higher com-
pared to D26 monolayer cultures. Most notably the transcript
level of UDP glucuronosyltransferase 1A1 (UGT1A1), a gene
encoding an enzyme involved in bilirubin conjugation in the
liver, increased about 60-fold in spheroids comparing to
about 2-fold increase in monolayer culture. The level of ALB
transcript increased by about 16-fold over the 6 days in
spheroids, but remained relatively unchanged in monolayer
culture. The level of increase was more moderate for other
genes, including arginase 1 (ARG1), an enzyme involved in
the urea cycle, hepatocyte nuclear factor 4a (HNF4a), a liver
enriched transcription factor, Factor VII (FVII), a member of
coagulation factor family, and connexin 32 (CX32), a gap
junction protein. Nevertheless, the levels of transcripts of
those genes were all higher than the levels in cells main-
tained in monolayer culture.
The expression level of most mature hepatic transcripts, in-
cluding ALB, ARG1, UGT1A1, HNF4a, and FVII were main-
tained tillD35 in the3Dspheroidculture (Fig. 3). In comparison,
the expression levels of these genes in the monolayer culture
either remained at a constant but lower level than the spheroid
culture or decreased in the same period.
Expression of hepatic proteins in spheroids
The differentiation of ESCs to the hepatic lineage yields
heterogeneous progeny containing cells with different degrees
of hepatocyte maturation, as well as other less well-identified
cells. We examined the expression of two mature liver specific
proteins; ASGPR-1 and PEPCK (Fig. 3g, h) in the spheroids by
flow cytometry. ASGPR-1 plays an important role in the up-
take and degradation of glycoproteins with exposed terminal
galactose or N-acetylgalatosamine, while PEPCK is a pivotal
enzyme in gluconeogenesis in liver. On D20, *16% of the
hESC hepatic progeny were ASGPR-1 positive. The fraction of
ASGPR-1 positive cells increased to 60% on D26, after spher-
oid formation. A similar increase with the fraction of cells
staining positive for PEPCK was seen, from 17% on D20 to
70% on D26, and about 80% on D32. In both cases, the per-
centage of cells expressing the hepatic-specific proteins in-
creased significantly in spheroid cultures. The presence of
PEPCK protein was confirmed by immunostaining after cell
permeabilization (Fig. 3i). Further immunohistochemistry on
D32 spheroids for alpha-fetoprotein (AFP), ALB, CK8, and
CK18 is shown in Supplementary Fig. S3.
FIG. 1. Formation and characterization of 3D Spheroids (a)
Morphology of human embryonic stem cell (hESC) derived 3D
differentiated spheroids (Day 26), (scale bar 200mm); (b–e) Live-
dead viability staining during spheroid formation immediately
after seeding on D20 (b, 2.5· ; d, 10· ) and 24h after formation
on D21 (c, 2.5· ; e, 20· ), live, viable cells labeled with green
fluorescence, and nonviable cells labeled with red fluorescence
(scale bars forb and c 400mm, scale bars ford and e 100mm); (f–i)
Time-lapse images of spheroid formation with 1% of bulk
population labeledwithDiImembrane stain (scale bars 100mm).
Color images available online at www.liebertpub.com/scd
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Structural characteristics of spheroids
Under scanning electron microscopy (SEM), the spher-
oids appear densely packed; the boundaries of individual
cells were nearly indistinguishable (Fig. 4a, b). A micro-
graph with a higher magnification is shown in Fig. 4b.
Typical hepatocyte morphology can be seen on cell clusters
on the exterior of the aggregate (Fig. 4c) with some polyg-
onal cells exhibiting abundant microvilli on the cell surface
(Fig. 4d).
TEM revealed that cells in the spheroids on D30 displayed
the typical polygonal morphology with numerous microvilli
FIG. 2. Relative transcript levels in differ-
entiated spheroids. Change in transcript
level of liver specific genes on D26 relative to
the starting cells at D20 for cells formed 3D
spheroid (-) and maintained as monolayer
(,) (average of n = 3). The transcript levels
were normalized to that of GAPDH of the
same sample. The fold changes of gene ex-
pression in D26 cells relative to D20 cells are
shown. The higher value thus, represents
higher extent of increase in the transcript
level.
FIG. 3. Sustaining differentiated properties in spheroids. The level of transcript is expressed as a relative value to that at D20 in
(-) spheroid culture; (,): monolayer culture (average of n= 3) for (a)AFP; (b)ALB; (c)ARG1; (d)HNF4A; (e)UGT1A1; (f) FVII;
(The expression level at D20 ismarkedwith dash line); (g)ASGPR-1 expression by FACS analysis preceding spheroid formation at
D20 (blue) and after at D26 (red) (isotypematched control in green); (h) Phosphoenolpyruvate carboxykinase (PEPCK) expression
by FACS analysis at D20 (blue), D26 (red) and D32 (brown) (isotype matched control in green); (i) immunostaining (green) of
PEPCK in spheroids with 4¢,6-diamidino-2-phenylindole nuclear counter stain (blue) (scale bar, 50mm); (j)Albumin secretion by
enzyme-linked immunosorbent assay analysis in monolayer (,) and spheroid (-). Color images available online at
www.liebertpub.com/scd
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(Fig. 4e). Intercellular bile-canaliculi delimited by tight
junctions were also observed; Golgi apparatus, plentiful
mitochondria, lipid droplets, and rough endoplasmic retic-
ulum were all seen. Lysosomes and inter-cellular coated
vesicles involved in degrading biological materials were also
visible.
Hepatocytes exhibit polarized surface domains even in
culture. In vivo they excrete bile acid into the bile canaliculi.
In culture, they accumulate excreted chemical species in the
space in between cells. Incubation with a dilute solution of
fluorescein diacetate, which forms fluorescent fluorescein
upon intracellular cleavage by esterase, results in an accu-
mulation of excreted fluorescein in the intercellular space.
This has been used as an indication of polarization of cel-
lular surface domains [22,23]. Spheroids at D32 were incu-
bated in 3 mg/mL of fluorescein diacetate, and the
accumulation of fluorescein in the intercellular space was
visible by confocal imaging (Fig. 4j), indicating cell polari-
zation.
Functional activity of HESC derived spheroids
We next evaluated a number of hepatic activities in the
hESC derived hepatocyte-like cells and compared the level in
spheroids to that in cells maintained as monolayer. The cell
numbers of spheroids in wells were enumerated and the
average ALB secretion rate was estimated. ALB secretion
rate, initially at 1.83 pg/cell/day on D20 before spheroid
formation increased to 4.52 and 12.05 pg/cell/day on D26
and D32 respectively in spheroid culture, but subsided to
0.45 and 0.53 pg/cell/day in monolayer culture on D26 and
D32 (Fig. 3j). Thus, spheroid formation resulted in a sub-
stantial increase in the ALB secretion rate, and the higher rate
was sustained over the cultivation period.
We also assessed Cyp1A1/2 and Cyp2B6/7 activity by
ethoxyresorufin-O-dealkylation (EROD) and pentoxyresor-
ufin-O-dealkylation (PROD) reactions. The intracellular ac-
cumulation of the fluorescent resorufin after the cleavage of
ethoxyresorufin or pentoxyresorufin, indicative of EROD
FIG. 4. Images of hESC derived hepatic-like cell spheroids. Scanning electron microscopy images of hESC derived spheroids
on D30 at (a) 70· (scale bar, 500mm), (b) 200· (scale bar, 200mm), (c) 1,000· (scale bar, 50mm), (d) 7,000· (scale bar, 5mm). (e)
Transmission electron microscopic micrographs of hESC-derived spheroids on D30. Labels: nucleus (N); microvilli (MV); bile-
canaliculi (BC); tight junctions (TJ); golgi body (GB); mitochondria (M); lipid droplets (L); and rough endoplasmic reticulum
(rER) (scale bars: upper left panel, 10mm; lower left panel, 500 nm; all others 1mm). (f, g)Accumulation of fluorescent resorufin from
Ethoxyresorufin O-dealkylation reaction in D32 spheroids without (f) or with (g) 24h of b-naphthoflavone treatment. (h, i)
Accumulation of fluorescent resorufin from Pentoxyresorufin O-dealkylation reaction in D32 spheroids, without (h) or with (i)
24h of phenobarbital treatment. Insets show transmitted light images of the spheroids (scale bars, 50mm). (j) Polarized accu-
mulation of fluorescein in hESC derived spheroids (scale bar, 50mm). Color images available online atwww.liebertpub.com/scd
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(Fig. 4g) and PROD (Fig. 4i) activities was seen in spheroids
under confocal microscopy. The spheroids were then treated
with b-napthoflavone and Phenobarbital, inducers of
Cyp1A1 and Cyp2B6/7, respectively. A modest increase in
EROD activity after b-napthoflavone treatment (Fig. 4g) was
observed, but little change was observed in PROD activity
after Phenobarbital treatment (Fig. 4i).
EROD and PROD activities were also quantified by mea-
suring the rate of resorufin product release into the media
(Supplementary Fig. S4a, b). Resorufin release increased
nearly five-fold after b-napthoflavone induction but not after
Rifampicin treatment (EROD assay). Likewise, resorufin re-
lease increased marginally after treatment with Phenobarbi-
tal but not Rifampicin (PROD assay).
To further interrogate the phenomenon of specific CYP450
activity, the expression of the relevant CYP450 gene products
were evaluated by quantitative PCR with or without drug
treatment (Supplementary Fig. S4c, d). Cyp1a1 transcript
expression increased 24-fold after 24 h of b-napthoflavone
induction, while Rifampicin treatment resulted in minimal
change in Cyp1a1 expression. Thus, consistent results were
seen for intracellular accumulation and excretion of resorufin
and transcript levels for the specific Cyp450: induction of
Cyp1A1/2 expression and function by b-napthoflavone, but
no increase in expression and function of Cyp2B6/7 by Phe-
nobarbital.
Discussion
In this study, we extended our monolayer hESC differ-
entiation into three-dimensional spheroid culture. After a 20-
day differentiation that directed cells to the hepatic lineage,
cultivation of the cells as spheroids resulted in enhanced
expression of many hepatic lineage markers. This was illus-
trated by the increased gene expression at the transcript level
for a number of liver specific genes, including UGT1A1 and
ARG1 (Fig. 2) and protein levels for the intracellular enzyme
PEPCK and cell surface protein ASGPR1, and secreted ALB
(Fig. 3).
The 3D spheroid culture system also allowed maintenance
of the differentiation markers for an extended period. During
extended culture for 15 days in the spheroid system, ex-
pression levels of hepatic-specific transcripts were main-
tained at the level achieved after 6 days of spheroid culture
(Fig. 3). In contrast, the expression levels of hepatic tran-
scripts in cells that were maintained in monolayer culture
significantly decreased between D26 and D35. The results
suggest that the observed enhanced differentiation was not
merely an outcome of the extended culture period. It is more
probable that the process of self-assembly and the tissue-like
3D structure in the spheroid has a positive effect in the he-
patic differentiation.
After nearly 2 weeks in spheroid culture, hepatocyte-like
cells derived from hESCs still exhibited biological activity of
Cyp1A1/2 and Cyp2B6/7 enzymes as shown by EROD and
PROD reactions (Fig. 4). Cyp450 activities, responsible for
the biotransformation of many xenobiotics and the metabo-
lism of drugs, are vital functions in liver. Many of those
enzyme activities are induced by chemical inducers both
in vivo and in vitro in cultured hepatocytes. We demon-
strated that Cyp1A1/2 gene expression and enzyme function
in the spheroid cultures responded to the induction by b-
Napthoflavone. The increased activity was seen in the ac-
cumulation of resorufin product within the spheroids (Fig.
4), in the release of resorufin into the media (Supplementary
Fig. 4a, b), and expression of the gene transcripts (Supple-
mentary Fig. 4c, d). However, the Cyp2B6/7 activity as
measured by the PROD reaction did not respond to treat-
ment with the specific inducer Phenobarbital. The results are
similar to what others have observed in hepatocyte-like cells
derived from different stem cell systems, showing the in-
ducibility of Cyp1A2 level [16,17,24] but the lack of induc-
ibility in Cyp2B6 level [16,24].
Some hepatocyte-like cells exhibit morphology markedly
similar to mature hepatocyte in SEM (Fig. 4b, c), although
heterogeneity in morphology is also visible. Ultrastruc-
turally, the cells in the spheroids also exhibit features ex-
pected in mature liver cells, especially microvilli aligning the
canaliculi like openings. The extensive cell-cell interactions
are visible in TEM micrographs (Fig. 4e). The spatial polar-
ization is observed by secretion of fluorescein (Fig. 4j). The
ultrastructure did not reveal any necrosis despite the 100–
150mm size range. In previous studies with primary hepa-
tocytes (19) and rat adult bone marrow derived stem cells
(21), high viability was seen in spheroids with a similar size
range. How the viability or ultrastructure is affected by
different seeding cell densities is yet to be explored. The
structural characteristics of these spheroids show some re-
semblance to hepatocytes, which is consistent with the en-
hanced hepatocyte properties at transcript, protein and
functional levels.
Three-dimensional culture systems have been shown to
promote enhanced cellular structure and function in many
cell and tissue types, including mammary epithelial cells
[25], mesenchymal stem cells [26], neural cells [27], and he-
patic cells [19,28–34]. In those studies employing mouse, rat
or pig primary hepatocytes, cells were allowed to adhere to
moderate to low attachment surface to enhance spheroid
formation [33,35]. In other studies, primary hepatocytes were
cultivated in suspension with a stirred bioreactor to form
spheroids [36,37]. We recently reported three-dimensional
aggregate differentiation of rat multipotent adult progenitor
cells by allowing them to agglomerate in low attachment
plates. Increased transcript expression of liver specific genes,
ALB secretion, and enhanced activities of some CYP450 and
more profound ultrastructural characteristics of liver tissue
were observed as compared to the differentiation carried out
in monolayer culture [20].
In our differentiations, D20 cells mostly consist of a mix-
ture of fetal and adult hepatocyte like cells [11]. There are
likely other cell types present in the differentiated culture, as
suggested by the presence of AFP, PEPCK and ASGPR-1
negative cells in the population by flow cytometric assays
(Fig. 3). Transcript expression suggests presence of some
endothelial cells (VE-cadherin) although other lineage mark-
ers, such as SM22 (smooth muscle) and Nkx2.5 (pancreas)
remain relatively unchanged from D0 (Supplementary Fig.
S5).
Similar multistage differentiations from hESC and human
iPS cells toward hepatic lineages all yield cells expressing
apparently similar transient levels of AFP and ALB, with
levels of ALB expression similar to or exceeding expression in
primary hepatocytes [16,17,38]. AFP is expressed in fetal liver
cells but not in adult hepatocytes. In our case, the persistent
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expression of AFP, thus, suggests the presence of immature
fetal hepatocyte-like cells in the spheroids. Furthermore,
some nonhepatic cells are likely still present within the
spheroids and contribute to the heterogeneity of the cell
population as seen in flow cytometric assays.
Flow cytometry for ASGPR-1 clearly demonstrated a
definite enrichment of ASGPR-1 expressing cells on Day 26
of the 3D spheroid culture as compared to the Day 20 2D
culture. Likewise, the enrichment in the fraction of PEPCK
expressing cells from *17% in the Day 20 samples to about
70% in Day 32 samples was also observed. Such increase in
the fraction of more mature hepatocyte-like cells could be the
results of spheroid formation. Another possibility of the en-
richment of more mature cells in the initial phase of cell
agglomeration is through specific cell-cell interactions.
The enhancement of both the fraction of differentiated
cells and the liver specific gene expression through spheroid
formation, although significant, still falls short of reaching
the state of mature hepatocytes. This has been seen in all
reports of hepatic lineage differentiation from embryonic and
other stem cells. Recently, it was shown that overexpression
of exogenous FOXA2 and HNF1a via adenoviral vectors in
differentiating hESC or hiPSC increases the percentage of
cells reaching a more mature liver phenotype [24]. ALB ex-
pression in the differentiated progeny suggested that a very
high percentage of cells exhibit hepatocyte characteristics
with slight enhancement of CYP450 activities. Thus, en-
hancing functional maturity through overexpression of he-
patic transcription factors or genes may be worth exploring
In summary, we have developed a simple and reproduc-
ible differentiation method consisting of step-wise mono-
layer based directed differentiation to the hepatic endoderm
for 20 days, followed by a process of spontaneous self-
assembly of cells into three-dimensional spheroids that can
be maintained for at least an additional 15 days. This culture
system not only improves the phenotypic and functional
maturity of the differentiated cell population, but also allows
for a more efficient maintenance of the cells for an extended
culture time. This approach may thus, find application in
high-throughput drug screening, in BAL support devices, as
well as in hepatocyte transplantation.
Acknowledgments
K.S. was supported by a Graduate School fellowship from
University of Minnesota. D.J.O. was supported by an NSF fel-
lowship, Graduate School fellowship from University of Min-




No competing financial interests exist.
References
1. Jeon H and SG Lee. (2010). Living donor liver transplanta-
tion. Curr Opin Organ Transplant 15:283–287.
2. Hughes RD, RR Mitry and A Dhawan. (2012). Current status
of hepatocyte transplantation. Transplantation 93:342–347.
3. Soltys KA, A Soto-Gutierrez, M Nagaya, KM Baskin, M
Deutsch, R Ito, BL Shneider, R Squires, J Vockley, et al.
(2010). Barriers to the successful treatment of liver disease by
hepatocyte transplantation. J Hepatol 53:769–774.
4. Carpentier B, A Gautier and C Legallais. (2009). Artificial
and bioartificial liver devices: present and future. Gut
58:1690–1702.
5. Nyberg SL. (2012). Bridging the gap: advances in artificial
liver support. Liver Transpl 18 Suppl 2:S10–S14.
6. Haridass D, N Narain and M Ott. (2008). Hepatocyte
transplantation: waiting for stem cells. Curr Opin Organ
Transplant 13:627–632.
7. Sartipy P, P Bjorquist, R Strehl and J Hyllner. (2007). The
application of human embryonic stem cell technologies to
drug discovery. Drug Discov Today 12:688–699.
8. Dalgetty DM, CN Medine, JP Iredale and DC Hay. (2009).
Progress and future challenges in stem cell-derived liver
technologies. Am J Physiol Gastrointest Liver Physiol
297:G241–G248.
9. Jensen J, J Hyllner and P Bjorquist. (2009). Human embry-
onic stem cell technologies and drug discovery. J Cell Phy-
siol 219:513–519.
10. Imamura T, L Cui, R Teng, K Johkura, Y Okouchi, K Asa-
numa, N Ogiwara and K Sasaki. (2004). Embryonic stem
cell-derived embryoid bodies in three-dimensional culture
system form hepatocyte-like cells in vitro and in vivo. Tissue
Eng 10:1716–1724.
11. Roelandt P, KA Pauwelyn, P Sancho-Bru, K Subramanian, B
Bose, L Ordovas, K Vanuytsel, M Geraerts, M Firpo, et al.
(2010). Human embryonic and rat adult stem cells with
primitive endoderm-like phenotype can be fated to defini-
tive endoderm, and finally hepatocyte-like cells. PLoS One
5:e12101.
12. Agarwal S, KL Holton and R Lanza. (2008). Efficient dif-
ferentiation of functional hepatocytes from human embry-
onic stem cells. Stem Cells 26:1117–1127.
13. Si-Tayeb K, FK Noto, M Nagaoka, J Li, MA Battle, C Duris,
PE North, S Dalton and SA Duncan. (2009). Highly efficient
generation of human hepatocyte-like cells from induced
pluripotent stem cells. Hepatology 51:297–305.
14. Touboul T, NR Hannan, S Corbineau, A Martinez, C Mar-
tinet, S Branchereau, S Mainot, H Strick-Marchand, R Ped-
ersen, et al. (2010). Generation of functional hepatocytes
from human embryonic stem cells under chemically defined
conditions that recapitulate liver development. Hepatology
51:1754–1765.
15. Snykers S, J De Kock, V Rogiers and T Vanhaecke. (2009). In
vitro differentiation of embryonic and adult stem cells into
hepatocytes: state of the art. Stem Cells 27:577–605.
16. Asgari S, M Moslem, K Bagheri-Lankarani, B Pournasr, M
Miryounesi and H Baharvand. (2011). Differentiation and
transplantation of human induced pluripotent stem cell-
derived hepatocyte-like cells. Stem Cell Rev 9:493–504.
17. Chen YF, CY Tseng, HWWang, HC Kuo, VW Yang and OK
Lee. (2012). Rapid generation of mature hepatocyte-like cells
from human induced pluripotent stem cells by an efficient
three-step protocol. Hepatology 55:1193–1203.
18. Peshwa MV, FJ Wu, HL Sharp, FB Cerra and WS Hu. (1996).
Mechanistics of formation and ultrastructural evaluation of
hepatocyte spheroids. In Vitro Cell Dev Biol Anim 32:197–203.
19. Tostoes RM, SB Leite, M Serra, J Jensen, P Bjorquist, MJ
Carrondo, C Brito and PM Alves. (2012). Human liver cell
spheroids in extended perfusion bioreactor culture for re-
peated-dose drug testing. Hepatology 55:1227–1236.
20. Subramanian K, DJ Owens, TD O’Brien, CM Verfaillie and
WS Hu. (2011). Enhanced differentiation of adult bone
130 SUBRAMANIAN ET AL.
marrow-derived stem cells to liver lineage in aggregate
culture. Tissue Eng Part A 17:2331–2341.
21. Tzanakakis ES, CC Hsiao, T Matsushita, RP Remmel and
WS Hu. (2001). Probing enhanced cytochrome P450 2B1/2
activity in rat hepatocyte spheroids through confocal laser
scanning microscopy. Cell Transplant 10:329–342.
22. Bravo P, V Bender and D Cassio. (1998). Efficient in vitro
vectorial transport of a fluorescent conjugated bile acid an-
alogue by polarized hepatic hybrid WIF-B and WIF-B9 cells.
Hepatology 27:576–583.
23. Oude Elferink RP, DK Meijer, F Kuipers, PL Jansen, AK
Groen and GM Groothuis. (1995). Hepatobiliary secretion of
organic compounds; molecular mechanisms of membrane
transport. Biochim Biophys Acta 1241:215–268.
24. Takayama K, M Inamura, K Kawabata, M Sugawara, K
Kikuchi, M Higuchi, Y Nagamoto, H Watanabe, K Tashiro,
et al. (2012). Generation of metabolically functioning hepa-
tocytes from human pluripotent stem cells by FOXA2 and
HNF1alpha transduction. J Hepatol 57:628–636.
25. Weaver VM, S Lelievre, JN Lakins, MA Chrenek, JC Jones, F
Giancotti, Z Werb and MJ Bissell. (2002). beta4 integrin-
dependent formation of polarized three-dimensional
architecture confers resistance to apoptosis in normal and
malignant mammary epithelium. Cancer Cell 2:205–216.
26. Frith JE, B Thomson and PG Genever. (2010). Dynamic
three-dimensional culture methods enhance mesenchymal
stem cell properties and increase therapeutic potential. Tis-
sue Eng Part C Methods 16:735–749.
27. Simao D, I Costa, M Serra, J Schwarz, C Brito and PM Alves.
(2011). Towards human central nervous system in vitro
models for preclinical research: strategies for 3D neural cell
culture. BMC Proc 5 Suppl 8:P53.
28. Landry J, D Bernier, C Ouellet, R Goyette and N Marceau.
(1985). Spheroidal aggregate culture of rat liver cells: histo-
typic reorganization, biomatrix deposition, and maintenance
of functional activities. J Cell Biol 101:914–923.
29. Kelm JM, NE Timmins, CJ Brown, M Fussenegger and LK
Nielsen. (2003). Method for generation of homogeneous
multicellular tumor spheroids applicable to a wide variety of
cell types. Biotechnol Bioeng 83:173–180.
30. Keller PJ, F Pampaloni and EH Stelzer. (2006). Life sciences
require the third dimension. Curr Opin Cell Biol 18:117–124.
31. Griffith LG and MA Swartz. (2006). Capturing complex 3D
tissue physiology in vitro. Nat Rev Mol Cell Biol 7:211–
224.
32. Cukierman E, R Pankov, DR Stevens and KM Yamada.
(2001). Taking cell-matrix adhesions to the third dimension.
Science 294:1708–1712.
33. Abu-Absi SF, JR Friend, LK Hansen and WS Hu. (2002).
Structural polarity and functional bile canaliculi in rat he-
patocyte spheroids. Exp Cell Res 274:56–67.
34. Leite SB, I Wilk-Zasadna, JM Zaldivar, E Airola, MA Reis-
Fernandes, M Mennecozzi, C Guguen-Guillouzo, C Chesne,
C Guillou, PM Alves and S Coecke. (2012). Three-dimen-
sional HepaRG model as an attractive tool for toxicity test-
ing. Toxicol Sci 130:106–116.
35. Tsuchiya A, T Heike, H Fujino, M Shiota, K Umeda, M
Yoshimoto, Y Matsuda, T Ichida, Y Aoyagi and T Nakahata.
(2005). Long-term extensive expansion of mouse hepatic
stem/progenitor cells in a novel serum-free culture system.
Gastroenterology 128:2089–2104.
36. Lazar A, HJ Mann, RP Remmel, RA Shatford, FB Cerra and
WS Hu. (1995). Extended liver-specific functions of porcine
hepatocyte spheroids entrapped in collagen gel. In Vitro Cell
Dev Biol Anim 31:340–346.
37. Wu FJ, JR Friend, CC Hsiao, MJ Zilliox, WJ Ko, FB Cerra and
WS Hu. (1996). Efficient assembly of rat hepatocyte spher-
oids for tissue engineering applications. Biotechnol Bioeng
50:404–415.
38. Nakamura N, K Saeki, M Mitsumoto, S Matsuyama, M
Nishio, M Hasegawa, Y Miyagawa, H Ohkita, N Kiyokawa,
et al. (2012). Feeder-free and serum-free production of
hepatocytes, cholangiocytes, and their proliferating progen-
itors from human pluripotent stem cells: application to liver-




Department of Chemical Engineering and Materials Science
University of Minnesota
421 Washington Avenue SE
Minneapolis, MN 55455-0132
E-mail: acre@cems.umn.edu
Received for publication February 14, 2013
Accepted after revision September 8, 2013
Prepublished on Liebert Instant Online September 11, 2013
ENHANCING HEPATIC DIFFERENTIATION OF ES CELLS 131
